Literature DB >> 7721609

Tumor blood flow measurements using coincidence counting on patients treated with neutrons.

E R Hering1, G H Blekkenhorst, D T Jones.   

Abstract

PURPOSE: The purpose of this work was to measure blood flow in tumors using a coincidence counting technique on patients undergoing treatment with neutrons. METHODS AND MATERIALS: The half-time, Tw, for the washout of 15O from neutron-activated tumors was measured with two 10 cm NaI(Tl) crystals coupled to a PC-based coincidence counting system. Blood flow measurements were made in 33 patients, 19 of whom had cancers of the head and neck region, 6 had breast cancer, 5 had sarcomas, and 3 patients had mesotheliomas.
RESULTS: Blood flow as indicated by Tw of mobile 15O formed by neutron activation could be readily determined in tumors of patients undergoing neutron radiotherapy. The general reduction in the value for Tw was noted towards the end of treatment and did not seem to be dependent on the initial tumor volume. There was a tendency for larger lesions to be associated with longer half-times of 15O washout.
CONCLUSION: It appears possible to obtain a reasonable estimate of tumor blood flow using a simple coincidence counting technique. In view of the large variation in blood flow between tumors, it did not appear to be possible to identify potentially hypoxic tumors that would respond to neutron therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7721609     DOI: 10.1016/0360-3016(94)00509-J

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  1 in total

1.  Elucidation of the tumoritropic principle of hypericin.

Authors:  M Van de Putte; T Roskams; J R Vandenheede; P Agostinis; P A M de Witte
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.